Lemaitre Vascular (LMAT) Cash Flow Statement

Click line-items for a historical chart and %

Net income	7.99M
Depreciation and amortization	2.66M
Stock-based compensation	1.2M
Amortization of premium on marketable securities
Impairment charges
Provision for losses in accounts receivable
Provision for inventory write-downs	280K
Provision for deferred income taxes
Noncash restructuring charges
Foreign currency transaction (gain) loss	-1K
Accounts receivable	-68K
Inventory	-216K
Prepaid expenses and other assets	-390K
Accounts payable and other liabilities	1.2M
Net cash provided by operating activities
Purchases of property and equipment
Payments related to acquisitions
Receipts related to divestitures	0
Purchase of technology and licenses
Sales and maturities of marketable securities
Net cash used in investing activities
Proceeds from issuance of common stock
Payments of Italian government loan
Purchase of treasury stock	-183K
Common stock cash dividend paid	-2.49M
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents	230K
Net increase (decrease) in cash and cash equivalents	7.2M
Cash and cash equivalents at beginning of period	27.45M
Cash and cash equivalents at end of period	34.65M

Entities mentioned with LMAT

View All Entities